Patent details

Basic Information

Publication number:

EP2504435

PCT Application Number:

US2010058123

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP107855710

PCT Publication Number:

WO2011066475

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SIRNA COMPOUNDS COMPRISING TERMINAL SUBSTITUTIONS

French Title of Invention:

COMPOSÉS D'ARNSI COMPORTANT DES SUBSTITUTIONS TERMINALES

German Title of Invention:

SIRNA-VERBINDUNGEN MIT TERMINALEN SUBSTITUTIONEN

SPC Number:

Dates

Filing date:

25/11/2010

Grant date:

13/11/2019

EP Publication Date:

03/10/2012

PCT Publication Date:

03/06/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/11/2019

EP B1 Publication Date:

13/11/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

25/11/2019

Expiration date:

25/11/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/11/2019

 

 

Name:

Quark Pharmaceuticals, Inc.

Address:

7999 Gateway Boulevard, Suite 310, Newark, CA 94560, United States (US)

Inventor

Name:

AVKIN-NACHUM, Sharon

Address:

Israel (IL)

Priority

1

Priority Number:

264668 P

Priority Date:

26/11/2009

Priority Country:

United States (US)

2

Priority Number:

295721 P

Priority Date:

17/01/2010

Priority Country:

United States (US)

3

Priority Number:

372072 P

Priority Date:

09/08/2010

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/713; C12N 15/113;

Publication

European Patent Bulletin

Issue number:

201946

Publication date:

13/11/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages